Latest research report on “Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market” now available at high quality database of ReportsnReports.com with market size, share, trends, competitive and statistical analysis. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample Copy @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5555493
Chemotherapy-induced nausea and vomiting (CINV) is a common side-effect of many cancer treatments. Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families. In 1983, Coates et al. found that patients receiving chemotherapy ranked nausea and vomiting as the first and second most severe side effects, respectively. Up to 20% of patients receiving highly emetogenic agents in this era postponed, or even refused, potentially curative treatments. Since the 1990s, several novel classes of antiemetics have been developed and commercialized, becoming a nearly universal standard in chemotherapy regimens, and helping to better manage these symptoms in a large portion of patients. Efficient mediation of these unpleasant and sometimes crippling symptoms results in increased quality of life for the patient, and better overall health of the patient, and, due to better patient tolerance, more effective treatment cycles.
This report contains market size and forecasts of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs in global, including the following market information:
Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Chemotherapy Induced Nausea and Vomiting (CINV) Drugs companies in 2021 (%)
The global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market was valued at 2125.8 million in 2021 and is projected to reach US$ 2819.2 million by 2028, at a CAGR of 4.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
5-HT3 Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs include Merck, Eisai, Mundipharma, Qilu Pharma, Teva, Novartis, Heron Therapeutics, Roche and Mylan and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Chemotherapy Induced Nausea and Vomiting (CINV) Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Segment Percentages, by Type, 2021 (%)
– 5-HT3 Inhibitors
– NK1 Inhibitors
– Other
Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Segment Percentages, by Application, 2021 (%)
– Highly Emetogenic Chemotherapy
– Moderately Emetogenic Chemotherapy
– Low Emetogenic Chemotherapy
– Other
Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Segment Percentages, By Region and Country, 2021 (%)
– North America
– – US
– – Canada
– – Mexico
– Europe
– – Germany
– – France
– – U.K.
– – Italy
– – Russia
– – Nordic Countries
– – Benelux
– – Rest of Europe
– Asia
– – China
– – Japan
– – South Korea
– – Southeast Asia
– – India
– – Rest of Asia
– South America
– – Brazil
– – Argentina
– – Rest of South America
– Middle East & Africa
– – Turkey
– – Israel
– – Saudi Arabia
– – UAE
– – Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chemotherapy Induced Nausea and Vomiting (CINV) Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Chemotherapy Induced Nausea and Vomiting (CINV) Drugs revenues share in global market, 2021 (%)
Key companies Chemotherapy Induced Nausea and Vomiting (CINV) Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Chemotherapy Induced Nausea and Vomiting (CINV) Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
– Merck
– Eisai
– Mundipharma
– Qilu Pharma
– Teva
– Novartis
– Heron Therapeutics
– Roche
– Mylan
– Tesaro
More information about Discount offers (25% or More) @ https://www.reportsnreports.com/contacts/discount.aspx?name=5555493
About Us: ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
We provide 24/7 online and offline support to our customers.
E-mail: [email protected]
Phone: +1 888 391 5441